AQR Capital Management - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$178,000
-22.6%
26,115
-20.0%
0.00%
Q1 2021$230,000
+12.7%
32,6260.0%0.00%
Q4 2020$204,000
+21.4%
32,626
+5.3%
0.00%
Q3 2020$168,000
+162.5%
30,996
+152.5%
0.00%
Q2 2020$64,000
-61.4%
12,277
-4.0%
0.00%
Q1 2018$166,000
-49.7%
12,789
-30.6%
0.00%
Q4 2017$330,000
-28.7%
18,4310.0%0.00%
-100.0%
Q3 2017$463,00018,4310.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,387,172$6,537,0001.72%
Worth Venture Partners, LLC 969,698$2,366,0001.39%
Omega Fund Management, LLC 1,971,241$3,804,0001.21%
Telemetry Investments, L.L.C. 495,000$955,0001.13%
CM Management, LLC 350,000$676,0000.72%
Bruce & Co., Inc. 1,557,312$3,005,0000.71%
Trellus Management Company, LLC 295,000$569,0000.69%
Abingworth LLP 1,041,131$1,999,0000.64%
1492 Capital Management LLC 489,376$944,0000.62%
GENERAL AMERICAN INVESTORS CO INC 1,752,470$3,382,0000.34%
View complete list of PARATEK PHARMACEUTICALS INC shareholders